(NASDAQ: JAN) JANONE INC. shares popped up 40% on news this morning. Shares are surging at $3.48 as traders have more than 30,000 trades on heavy volume.

LAS VEGAS, June 7, 2022 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced today that a patent was issued that covers a method of improving nerve function using JAN101. JAN101 (formerly known as TV1001SR), is a potential treatment for peripheral artery disease (PAD), a vascular disease that affects more than 8.5 million people in the U.S. and more than 60 million people worldwide.

https://ir.janone.com/news-events/press-releases/detail/44/janone-inc-announces-the-issuance-of-u-s-patent-covering